Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Siemens AG    SIE   DE0007236101

SIEMENS AG (SIE)

323
Real-time Quote. Real-time TRADEGATE AG - 10/24 10:01:45 pm
86.5160 EUR   +0.49%
8h ago Areva-Siemens raises claim to $4.4 billion over Finnish reactor delays
2d ago Network gear maker Nokia tops market expectations
3d ago Global growth worries take shine off ABB's order surge
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Siemens AG : WSJ BLOG/Health : Siemens Sees Resurgence in Diagnostics as a Cost Cutter

04/13/2012 | 01:02pm US/Eastern

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Shirley S. Wang

The Health Blog caught up at TEDMED with Gregory Sorensen, chief executive of Siemens Healthcare in North America, to talk about the changing health-care field and what it means for diagnostics, an area in which Siemens is a player.

"We're beginning to see resurgence in diagnostics as a way to save costs, " Sorensen, formerly a radiology professor at Harvard Medical School, told the Health Blog.

A missed diagnosis is a big cost driver in health care because it wastes time and money on ineffective therapy, he said, pointing to an example of studies in Alzheimer's showing that upon autopsy, some 15%-20% of patients examined had a different ailment than believed and would have been treated differently when they were alive.

Of course, there's been an outcry about the unnecessary use of medical tests and Sorensen acknowledges there has been overuse in the past. Reductions in Medicare reimbursement rates have curbed overuse, he says, though not everyone agrees on that, as the Health Blog reported last week. The important thing now, Sorensen says, is to make sure people are getting the right diagnostic tests, rather than reduce the absolute number of them.

He recalled being a doctor in training in the late 1980s, when his professors taught him that, because of the risks associated with appendicitis, doctors should be conservative whenever a patient reported pain in the lower right quadrant of the abdomen. A good surgeon, therefore, would do exploratory surgery on five patients for every one that actually had appendicitis. Sorensen himself had his appendix -- which turned out to be healthy -- removed during this era.

Now patients get scanned if they report such pain, resulting in many fewer unnecessary surgeries, said Sorensen.

Siemens recognizes how important it is to demonstrate effectiveness in today's health-care business, and that payers want to see results, says Sorensen. As for the shift to reimbursement for value, "that train has left the station."

 
 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 
 

Latest news on SIEMENS AG
8h ago Areva-Siemens raises claim to $4.4 billion over Finnish reactor delays
1d ago SIEMENS : Wins Contract to Help National Park Service (NPS) Achieve Significant ..
2d ago SIEMENS : 'Let's see what we can do together to deliver new jobs and prosperity ..
2d ago SIEMENS : "We have to sell the region as a whole or we risk losing out to other,..
2d ago Network gear maker Nokia tops market expectations
2d ago INDUS MOTOR : ISE-10 index stays bullish
2d ago SIEMENS : Giants completed for Siemens Wind Power GmbH
2d ago SIEMENS : Report Summarizes Magnetic Resonance Study Findings from Siemens (High..
3d ago Global growth worries take shine off ABB's order surge
3d ago SIEMENS : New Medical Imaging Findings from Siemens Discussed (Pose-independent ..
Advertisement
Chart
Duration : Period :
Siemens AG Technical Analysis Chart | SIE | DE0007236101 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF